All Stories

  1. Infectious disease outbreak controllability: biological, social and public health factors
  2. Uncertainty Quantification in Cost-effectiveness Analysis for Stochastic-based Infectious Disease Models: Insights from Surveillance on Lymphatic Filariasis
  3. Natural history of a parasite-induced biliary cancer
  4. Health and economic impacts of Lassa vaccination campaigns in West Africa
  5. The Hidden Hand of Asymptomatic Infection Hinders Control of Neglected Tropical Diseases: A Modeling Analysis
  6. How does the proportion of never treatment influence the success of mass drug administration programmes for the elimination of lymphatic filariasis?
  7. Persons ‘never treated’ in mass drug administration for lymphatic filariasis: identifying programmatic and research needs from a series of research review meetings 2020–2021
  8. The hidden hand of asymptomatic infection hinders control of neglected tropical diseases
  9. A modelling analysis of a new multi-stage pathway for classifying achievement of public health milestones for leprosy
  10. Introduction to the special issue: challenges and opportunities in the fight against neglected tropical diseases: a decade from the London Declaration on NTDs
  11. Diagnosis of helminths depends on worm fecundity and the distribution of parasites within hosts
  12. Health economic analyses of latent tuberculosis infection screening and preventive treatment among people living with HIV in lower tuberculosis incidence settings: a systematic review
  13. Estimating LFT and qPCR test-sensitivity over time since infection from a human challenge study
  14. An archetypes approach to malaria intervention impact mapping: a new framework and example application
  15. Impact of intensified control on visceral leishmaniasis in a highly-endemic district of Bihar, India: An interrupted time series analysis
  16. Gender-related differences in prevalence, intensity and associated risk factors of Schistosoma infections in Africa: A systematic review and meta-analysis
  17. The SARS-CoV-2 pandemic: remaining uncertainties in our understanding of the epidemiology and transmission dynamics of the virus, and challenges to be overcome
  18. Estimating HIV, HCV and HSV2 incidence from emergency department serosurvey
  19. How modelling can help steer the course set by the World Health Organization 2021-2030 roadmap on neglected tropical diseases
  20. Sustainable Surveillance of Neglected Tropical Diseases for the Post-Elimination Era
  21. Maintaining Low Prevalence of Schistosoma mansoni: Modeling the Effect of Less Frequent Treatment
  22. Forecasting Trachoma Control and Identifying Transmission-Hotspots
  23. What Can Modeling Tell Us About Sustainable End Points for Neglected Tropical Diseases?
  24. Modelling the Impact of Vector Control on Lymphatic Filariasis Programs: Current Approaches and Limitations
  25. Dynamics of SARS-CoV-2 with waning immunity in the UK population
  26. Engagement and adherence trade-offs for SARS-CoV-2 contact tracing
  27. Epidemic interventions: insights from classic results
  28. Strengthening data collection for neglected tropical diseases: What data are needed for models to better inform tailored intervention programmes?
  29. Health economic analyses of latent tuberculosis infection screening and preventive treatment among people living with HIV in lower tuberculosis incidence settings: a systematic review
  30. Evaluating the potential impact of interruptions to neglected tropical disease programmes due to COVID-19
  31. Modelling trachoma post-2020: opportunities for mitigating the impact of COVID-19 and accelerating progress towards elimination
  32. SCHISTOX: An individual based model for the epidemiology and control of schistosomiasis
  33. Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies
  34. Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
  35. Implications of the COVID-19 pandemic in eliminating trachoma as a public health problem
  36. Towards Evidence-based Control of Opisthorchis viverrini
  37. Forecasting trachoma control and identifying transmission-hotspots
  38. Responsible modelling: Unit testing for infectious disease epidemiology
  39. The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?
  40. Towards a comprehensive research and development plan to support the control, elimination and eradication of neglected tropical diseases
  41. Predicting the impact of disruptions in lymphatic filariasis elimination programmes due to the outbreak of coronavirus disease (COVID-19) and possible mitigation strategies
  42. Statistical methods for linking geostatistical maps and transmission models: Application to lymphatic filariasis in East Africa
  43. Modelling trachoma post 2020: Opportunities for mitigating the impact of COVID-19 and accelerating progress towards elimination
  44. Disruptions to schistosomiasis programmes due to COVID-19: an analysis of potential impact and mitigation strategies
  45. A novel age-structured mosquito model for assessing the mechanisms behind vector control success
  46. Defining a prevalence level to describe the elimination of Lymphatic Filariasis (LF) transmission and designing monitoring & evaluating (M&E) programmes post the cessation of mass drug administration (MDA)
  47. Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation
  48. Estimating how far and fast visceral leishmaniasis spreads around cases
  49. Engagement and adherence trade-offs for SARS-CoV-2 contact tracing
  50. Responsible modelling: Unit testing for infectious disease epidemiology
  51. Key questions for modelling COVID-19 exit strategies
  52. Integrating geostatistical maps and transmission models using adaptive multiple importance sampling
  53. COVID-19 spread in the UK: the end of the beginning?
  54. Dynamics of SARS-CoV-2 with Waning Immunity in the UK Population
  55. The potential impact of programmes interruptions due to COVID-19 on 7 neglected tropical diseases: a modelling-based analysis
  56. Achieving NTD Control, Elimination and Eradication Targets Post-2020: Modelling Perspectives and Priorities 
  57. Efficacy of contact tracing for the containment of the 2019 novel coronavirus (COVID-19)
  58. A novel age-structured mosquito model for assessing the mechanisms behind vector control success
  59. An imperfect tool: COVID-19 ‘test & trace’ success relies on minimising the impact of false negatives and continuation of physical distancing
  60. When, Who, and How to Sample: Designing Practical Surveillance for 7 Neglected Tropical Diseases as We Approach Elimination
  61. Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administration
  62. How universal does universal test and treat have to be?
  63. Erratum to: Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
  64. The use of mixture density networks in the emulation of complex epidemiological individual-based models
  65. Developments in statistical inference when assessing spatiotemporal disease clustering with the tau statistic
  66. How will country-based mitigation measures influence the course of the COVID-19 epidemic?
  67. Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis
  68. The Efficacy of Contact Tracing for the Containment of the 2019 Novel Coronavirus (COVID-19).
  69. Trachoma Prevalence After Discontinuation of Mass Azithromycin Distribution
  70. Elimination or Resurgence: Modelling Lymphatic Filariasis After Reaching the 1% Microfilaremia Prevalence Threshold
  71. Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?
  72. Mass deworming for improving health and cognition of children in endemic helminth areas: A systematic review and individual participant data network meta‐analysis
  73. Insights from quantitative and mathematical modelling on the proposed WHO 2030 goal for schistosomiasis
  74. Insights from mathematical modelling and quantitative analysis on the proposed WHO 2030 targets for visceral leishmaniasis on the Indian subcontinent
  75. Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison
  76. The roadmap towards elimination of lymphatic filariasis by 2030: insights from quantitative and mathematical modelling
  77. Evaluating the Evidence for Lymphatic Filariasis Elimination
  78. Guidelines for multi-model comparisons of the impact of infectious disease interventions
  79. Insights from quantitative and mathematical modelling on the proposed WHO 2030 goal for schistosomiasis
  80. Deworming children for soil-transmitted helminths in low and middle-income countries: systematic review and individual participant data network meta-analysis
  81. Community-based testing of migrants for infectious diseases (COMBAT-ID): impact, acceptability and cost-effectiveness of identifying infectious diseases among migrants in primary care: protocol for an interrupted time-series, qualitative and health eco...
  82. The use of mixture-density networks in the emulation of complex epidemiological individual-based models
  83. Age trends in asymptomatic and symptomatic Leishmania donovani infection in the Indian subcontinent: A review and analysis of data from diagnostic and epidemiological studies
  84. Identifying English Practices that Are High Antibiotic Prescribers Accounting for Comorbidities and Other Legitimate Medical Reasons for Variation
  85. Optimising sampling regimes and data collection to inform surveillance for trachoma control
  86. Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination
  87. The role of case proximity in transmission of visceral leishmaniasis in a highly endemic village in Bangladesh
  88. The impact of seasonality on the dynamics and control of Ascaris lumbricoides infections
  89. Correction to: The Dynamics of Ascaris lumbricoides Infections
  90. Complex interactions in soil-transmitted helminth co-infections from a cross-sectional study in Sri Lanka
  91. Diagnosing risk factors alongside mass drug administration using serial diagnostic tests—which test first?
  92. Counting Down the 2020 Goals for 9 Neglected Tropical Diseases: What Have We Learned From Quantitative Analysis and Transmission Modeling?
  93. Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models
  94. Assessing Strategies Against Gambiense Sleeping Sickness Through Mathematical Modeling
  95. Models of Trachoma Transmission and Their Policy Implications: From Control to Elimination
  96. Policy Lessons From Quantitative Modeling of Leprosy
  97. Policy Recommendations From Transmission Modeling for the Elimination of Visceral Leishmaniasis in the Indian Subcontinent
  98. Kernel-density estimation and approximate Bayesian computation for flexible epidemiological model fitting in Python
  99. Economic evaluations of lymphatic filariasis interventions: a systematic review and research needs
  100. Understanding heterogeneities in mosquito-bite exposure and infection distributions for the elimination of lymphatic filariasis
  101. Seasonally timed treatment programs for Ascaris lumbricoides to increase impact—An investigation using mathematical models
  102. Understanding the relationship between egg- and antigen-based diagnostics of Schistosoma mansoni infection pre- and post-treatment in Uganda
  103. 100 Years of Mass Deworming Programmes: A Policy Perspective From the World Bank's Disease Control Priorities Analyses
  104. Variations in visceral leishmaniasis burden, mortality and the pathway to care within Bihar, India
  105. Mass Deworming Programs in Middle Childhood and Adolescence
  106. Targeted Treatment of Yaws With Household Contact Tracing: How Much Do We Miss?
  107. Economic Evaluations of Mass Drug Administration: The Importance of Economies of Scale and Scope
  108. Investment in child and adolescent health and development: key messages from Disease Control Priorities , 3rd Edition
  109. Cost-effectiveness of screening for HIV in primary care: a health economics modelling analysis
  110. Innovative tools and approaches to end the transmission of Mycobacterium leprae
  111. Economic Considerations for Moving beyond the Kato-Katz Technique for Diagnosing Intestinal Parasites As We Move Towards Elimination
  112. Effectiveness of a triple-drug regimen for global elimination of lymphatic filariasis: a modelling study
  113. Elimination of visceral leishmaniasis in the Indian subcontinent: a comparison of predictions from three transmission models
  114. Learning from multi-model comparisons: Collaboration leads to insights, but limitations remain
  115. Measuring and modelling the effects of systematic non-adherence to mass drug administration
  116. Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework
  117. Making Transmission Models Accessible to End-Users: The Example of TRANSFIL
  118. Retinal pigment epithelium and microglia express the CD5 antigen-like protein, a novel autoantigen in age-related macular degeneration
  119. A strengthening evidence-base for mass deworming, but questions remain
  120. Development and evaluation of a Markov model to predict changes in schistosomiasis prevalence in response to praziquantel treatment: a case study of Schistosoma mansoni in Uganda and Mali
  121. Cost-effectiveness of scaling up mass drug administration for the control of soil-transmitted helminths: a comparison of cost function and constant costs analyses
  122. Analysis of the population-level impact of co-administering ivermectin with albendazole or mebendazole for the control and elimination of Trichuris trichiura
  123. Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection
  124. Key traveller groups of relevance to spatial malaria transmission: a survey of movement patterns in four sub-Saharan African countries
  125. The Dynamics of Ascaris lumbricoides Infections
  126. Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection
  127. Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India
  128. The Role of More Sensitive Helminth Diagnostics in Mass Drug Administration Campaigns
  129. Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and Apoptosis
  130. Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent
  131. Quantitative analyses and modelling to support achievement of the 2020 goals for nine neglected tropical diseases
  132. Bihar’s Pioneering School-Based Deworming Programme: Lessons Learned in Deworming over 17 Million Indian School-Age Children in One Sustainable Campaign
  133. An economic evaluation of expanding hookworm control strategies to target the whole community
  134. Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling
  135. Modelling strategies to break transmission of lymphatic filariasis - aggregation, adherence and vector competence greatly alter elimination
  136. Quantification of the natural history of visceral leishmaniasis and consequences for control
  137. Interrupting transmission of soil-transmitted helminths: a study protocol for cluster randomised trials evaluating alternative treatment strategies and delivery systems in Kenya
  138. MDA helminth control: more questions than answers
  139. Should the Goal for the Treatment of Soil Transmitted Helminth (STH) Infections Be Changed from Morbidity Control in Children to Community-Wide Transmission Elimination?
  140. Simple Approximations for Epidemics with Exponential and Fixed Infectious Periods
  141. Cost and cost-effectiveness of soil-transmitted helminth treatment programmes: systematic review and research needs
  142. Uniting mathematics and biology for control of visceral leishmaniasis
  143. Brief Report
  144. Modeling infectious disease dynamics in the complex landscape of global health
  145. Six challenges in the eradication of infectious diseases
  146. Seven challenges in modeling vaccine preventable diseases
  147. Seven challenges for model-driven data collection in experimental and observational studies
  148. Seven challenges for modelling indirect transmission: Vector-borne diseases, macroparasites and neglected tropical diseases
  149. Gradual acquisition of immunity to severe malaria with increasing exposure
  150. Fit for purpose: do we have the right tools to sustain NTD elimination?
  151. Infectious disease and health systems modelling for local decision making to control neglected tropical diseases
  152. Mass Drug Administration and beyond: how can we strengthen health systems to deliver complex interventions to eliminate neglected tropical diseases?
  153. High Transmissibility During Early HIV Infection Among Men Who Have Sex With Men—San Francisco, California: Table 1.
  154. Modeling the Interruption of the Transmission of Soil-Transmitted Helminths by Repeated Mass Chemotherapy of School-Age Children
  155. The coverage and frequency of mass drug administration required to eliminate persistent transmission of soil-transmitted helminths
  156. Virulence and Pathogenesis of HIV-1 Infection: An Evolutionary Perspective
  157. Can chemotherapy alone eliminate the transmission of soil transmitted helminths?
  158. UK malaria: increased risk for those visiting friends and relatives, business travellers & children
  159. How Effective Is School-Based Deworming for the Community-Wide Control of Soil-Transmitted Helminths?
  160. Heterosexual HIV-1 Infectiousness and Antiretroviral Use
  161. Transmission Dynamics of Ascaris lumbricoides – Theory and Observation
  162. Corrigendum to “27 years of the HIV epidemic amongst men having sex with men in the Netherlands: An in depth mathematical model-based analysis” [Epidemics 2 (2010) 66–79]
  163. Department of Error
  164. Optimisation of mass chemotherapy to control soil-transmitted helminth infection
  165. The Potential Contribution of Mass Treatment to the Control of Plasmodium falciparum Malaria
  166. Mitigation Strategies for Pandemic Influenza A: Balancing Conflicting Policy Objectives
  167. Interpretation of correlations in setpoint viral load in transmitting couples
  168. Reducing Plasmodium falciparum Malaria Transmission in Africa: A Model-Based Evaluation of Intervention Strategies
  169. 27 years of the HIV epidemic amongst men having sex with men in the Netherlands: An in depth mathematical model-based analysis
  170. HIV-1 Transmitting Couples Have Similar Viral Load Set-Points in Rakai, Uganda
  171. Modelling the between-host evolution of set-point viral load in HIV infection
  172. Corrigendum to “Variational data assimilation with epidemic models” [J. Theor. Biol. 258 (2009) 591–602]
  173. Controlling infectious disease outbreaks: Lessons from mathematical modelling
  174. Response--Influenza
  175. Variational data assimilation with epidemic models
  176. Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings
  177. Estimating the public health impact of the effect of herpes simplex virus suppressive therapy on plasma HIV-1 viral load
  178. 6.16 Mathematical models of transmission and control
  179. HIV-1 Transmission, by Stage of Infection
  180. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy
  181. Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis
  182. Frequent Travelers and Rate of Spread of Epidemics
  183. Will travel restrictions control the international spread of pandemic influenza?
  184. A comparison of methods for trend estimation